Concepts (78)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carcinoma, Non-Small-Cell Lung | 4 | 2018 | 106 | 1.820 |
Why?
|
| Lung Neoplasms | 4 | 2018 | 247 | 1.670 |
Why?
|
| Radiosurgery | 3 | 2018 | 17 | 1.080 |
Why?
|
| Radiation Oncology | 3 | 2022 | 7 | 0.950 |
Why?
|
| Brachytherapy | 2 | 2013 | 23 | 0.750 |
Why?
|
| Neoplasm Staging | 3 | 2018 | 168 | 0.730 |
Why?
|
| Surgical Oncology | 1 | 2020 | 4 | 0.620 |
Why?
|
| Physicians, Women | 1 | 2020 | 11 | 0.620 |
Why?
|
| Medical Oncology | 1 | 2020 | 23 | 0.620 |
Why?
|
| Faculty, Medical | 1 | 2020 | 34 | 0.600 |
Why?
|
| Academic Medical Centers | 1 | 2020 | 71 | 0.590 |
Why?
|
| Chemoradiotherapy, Adjuvant | 1 | 2018 | 4 | 0.550 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2018 | 22 | 0.540 |
Why?
|
| Pneumonectomy | 1 | 2018 | 34 | 0.530 |
Why?
|
| Adenocarcinoma | 1 | 2018 | 61 | 0.530 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2018 | 70 | 0.520 |
Why?
|
| Lymph Nodes | 1 | 2014 | 38 | 0.420 |
Why?
|
| Aged, 80 and over | 5 | 2018 | 2152 | 0.400 |
Why?
|
| Eye Neoplasms | 1 | 2013 | 1 | 0.400 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2018 | 85 | 0.390 |
Why?
|
| Uveal Neoplasms | 1 | 2012 | 1 | 0.370 |
Why?
|
| Organs at Risk | 1 | 2012 | 2 | 0.370 |
Why?
|
| Adult | 5 | 2020 | 3557 | 0.360 |
Why?
|
| Melanoma | 1 | 2012 | 34 | 0.360 |
Why?
|
| Radiotherapy Dosage | 3 | 2017 | 42 | 0.330 |
Why?
|
| Female | 7 | 2020 | 6974 | 0.330 |
Why?
|
| Humans | 10 | 2022 | 12240 | 0.320 |
Why?
|
| Aged | 6 | 2022 | 4000 | 0.300 |
Why?
|
| Middle Aged | 5 | 2018 | 4043 | 0.280 |
Why?
|
| Treatment Outcome | 3 | 2018 | 1478 | 0.270 |
Why?
|
| Male | 6 | 2018 | 6815 | 0.260 |
Why?
|
| Proportional Hazards Models | 2 | 2018 | 161 | 0.260 |
Why?
|
| Survival Rate | 2 | 2018 | 152 | 0.250 |
Why?
|
| Lymphatic Metastasis | 2 | 2017 | 51 | 0.230 |
Why?
|
| Young Adult | 2 | 2018 | 863 | 0.210 |
Why?
|
| Employment | 2 | 2022 | 22 | 0.190 |
Why?
|
| United States | 3 | 2022 | 989 | 0.190 |
Why?
|
| Chi-Square Distribution | 2 | 2018 | 60 | 0.170 |
Why?
|
| Internship and Residency | 1 | 2022 | 103 | 0.160 |
Why?
|
| Leadership | 1 | 2020 | 55 | 0.150 |
Why?
|
| Prognosis | 2 | 2018 | 363 | 0.150 |
Why?
|
| Prospective Studies | 2 | 2022 | 817 | 0.150 |
Why?
|
| Career Choice | 1 | 2018 | 13 | 0.140 |
Why?
|
| Follow-Up Studies | 2 | 2018 | 726 | 0.140 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 400 | 0.140 |
Why?
|
| Carcinoma, Adenosquamous | 1 | 2018 | 2 | 0.140 |
Why?
|
| SEER Program | 1 | 2018 | 8 | 0.140 |
Why?
|
| Carcinoma, Large Cell | 1 | 2018 | 7 | 0.140 |
Why?
|
| Lymphocytes | 1 | 2018 | 30 | 0.140 |
Why?
|
| Age Distribution | 1 | 2018 | 25 | 0.140 |
Why?
|
| Neutrophils | 1 | 2018 | 58 | 0.130 |
Why?
|
| Brain Neoplasms | 1 | 2018 | 35 | 0.130 |
Why?
|
| Patient Safety | 1 | 2017 | 16 | 0.130 |
Why?
|
| Disease-Free Survival | 1 | 2017 | 66 | 0.130 |
Why?
|
| Neoplasm Metastasis | 1 | 2017 | 53 | 0.130 |
Why?
|
| Registries | 1 | 2017 | 88 | 0.130 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 141 | 0.120 |
Why?
|
| Age Factors | 1 | 2017 | 350 | 0.120 |
Why?
|
| Cohort Studies | 1 | 2018 | 827 | 0.110 |
Why?
|
| Adolescent | 1 | 2018 | 989 | 0.110 |
Why?
|
| Tumor Burden | 1 | 2014 | 14 | 0.110 |
Why?
|
| Retrospective Studies | 2 | 2018 | 1467 | 0.100 |
Why?
|
| Macula Lutea | 1 | 2012 | 1 | 0.090 |
Why?
|
| Optic Disk | 1 | 2012 | 3 | 0.090 |
Why?
|
| Retina | 1 | 2012 | 4 | 0.090 |
Why?
|
| Software | 1 | 2012 | 26 | 0.090 |
Why?
|
| Lens, Crystalline | 1 | 2012 | 25 | 0.090 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 1 | 2012 | 23 | 0.090 |
Why?
|
| Equipment Design | 1 | 2012 | 76 | 0.090 |
Why?
|
| Medicare | 1 | 2022 | 59 | 0.050 |
Why?
|
| Cities | 1 | 2018 | 5 | 0.040 |
Why?
|
| Population Density | 1 | 2018 | 5 | 0.040 |
Why?
|
| Job Application | 1 | 2018 | 4 | 0.040 |
Why?
|
| Consumer Behavior | 1 | 2018 | 14 | 0.040 |
Why?
|
| Analysis of Variance | 1 | 2018 | 125 | 0.040 |
Why?
|
| Schools, Medical | 1 | 2018 | 15 | 0.040 |
Why?
|
| Leukocyte Count | 1 | 2018 | 35 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2018 | 546 | 0.030 |
Why?
|